ARRY — ARRAY BIOPHARMA INC

Ownership history in Engineers Gate Manager LP  ·  11 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in ARRAY BIOPHARMA INC (ARRY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.11% (2019 Q1)
Avg. % of fund
0.03%
First filed
2019 Q1
Last filed
2025 Q3
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 211,477 +54,240 +34.5% 0.02% $1.7M $8.15
2025 Q2 ADDED 157,237 +122,331 +350.5% 0.01% $928K $5.90
2024 Q4 REDUCED 34,906 -18,538 -34.7% 0.00% $211K $6.04
2024 Q3 ADDED 53,444 +41,365 +342.5% 0.01% $353K $6.60
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ARRY price (monthly, adj. close)

Other funds also holding ARRY

As of 2025 Q4 — sorted by position size

USCF Advisers LLC 6.13% DECADE RENEWABLE PARTNERS LP 3Y 4.71% Hill City Capital, LP 3Y 4.49% Redwood Grove Capital, LLC 3Y 4.34% Goodlander Investment Management, LLC 3.87% Villanova Investment Management Co LLC 1.22% Electron Capital Partners, LLC 3Y 7Y 1.13% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.56% Green Alpha Advisors, LLC 3Y 0.49% SILVERBACK ASSET MANAGEMENT LLC 3Y 7Y 0.4%
← Back to Engineers Gate Manager LP Holdings